chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had a sore arm for about a day. On 01/05/2023, I had mild sore throat and sneezing. I tested positive for COVID-19 on 01/06/2023 with a home test. I had a sore throat, headache, temperature, achy all over and sneezing. I called my doctor after testing positive and got a prescription for PAXLOVID. I am tolerating the medication without complications.
9/18 pt received Fluzone HD around 7:40pm.  In the evening (by pt), pt started to have itchiness.  Sunday pt woke up with mild headache and erythema on left arm lateral and back sides about 5x6cm which is red, hot and itch.  The erythema is right above pt's elbow.  Injection site is clear.  Pt said she had the same type of reaction with last year's flu vaccination.  She received flublok quad 2020-2021pfs.
Information has been received from a registered nurse via a company representative concerning a female patient "in her 50s", with an unknown medical history, who was vaccinated with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. Subsequently the patient experienced severe joint pain and fever. No other information is available. Unspecified medical attention was sought. Additional information has been requested.
Severe headache, fatigue, dizziness, off balance, and severe night sweats. Started the day after vaccine was given (8/20/2021)and is still happening.
My 15 year old son fainted. My son received the GARDASIL vaccine and a minute or so later and he started to feel dizzy. The nurse had given him a stop watch with 10 minutes on it and told him to sit. We were not informed that there was a high risk of syncope with GARDASIL. When he said the dizziness was not going away I rushed to get a nurse. I just happened to turn and check on him before leaving the room. I glanced back and saw my son going forward, head first, off the exam table and his eyes ere in the back of his head. He is 6'0 and 185 pounds. He was sitting cross legged on the table. I was able to reach him just in time before his head smashed to the ground. He was unconscious for another 8 seconds or so and then he came to.
9/21/11: severe abdominal pain that came on and subsided in waves, inconsolable crying, lethargy, disinterest in food, sleepiness, fussiness, significant blood in stool; symptoms grew worse over course of four hours and then began to improve somewhat; was taken to ER where ultrasound was performed at 10:00 PM that did not detect blockage 9/22/11: Numerous green stools throughout day indicative of diarrhea; took her to pediatrician for follow-up exam following ER visit; submitted stool sample for culture testing 9/23/11: Return of inconsolable crying in the afternoon around 3:30 PM, diarrhea worsened, persistent diarrhea caused severe and painful red diaper rash accompanied by yeast infection; treated with frequent hydration with nursing and anti-fungal/petroleum jelly applied to bottom to aid diaper rash
2mo infant rec'd DTP/OPV/HIBTITER on 23APR91; Found dead at the babysitter's 24APR91;
Patient woke up this morning  (5/25/22) and her right arm was flaccid, she was unable to use it.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The pertinent medical history and concomitant medication was not reported. On 23-JUN-2015, the patient was vaccinated with unspecified number of improperly stored doses of M-M-R II (lot: K004949 and Expiry: 04-APR-2016) (route unspecified). No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
rash began 2 days following the injections. It began as a ring about an inch from every injection and on the next day had covered her whole body except the face. she began zyrtec on the 4th day of the injections
Pt went into convulsion right after vaccine administration, lost consciousness, came back, started talking then went into seizure again. Provider evaluated child and was sent to hospital via ambulance.
Patient experienced flu-like symptoms including chills, fever, body ache, and hotness to touch for 5-6 days following the Shingrix vaccine administration. Patient self-treated with OTC acetaminophen.
I know people who got the new shingles shots and they got the shingles/SUSPECTED VACCINATION FAILURE; I know people who got the new shingles shots and they got the shingles; This case was reported by a consumer via  media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (patients got the shingles after the former shots (possible non GSK vaccine) also).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not applicable for this report. The reporter stated that he/she know patients (people) who got the new shingles shots and they got the shingles and the patients got the shingles after the former shots also, so why the urgency to rush out and get shots. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Moderate migraine headache; Achy joints; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6206) in the right arm on 11Mar2021 at 13:00 (at the age of 65-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8782) in the right arm on 01Apr2021 at 08:15 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, hypertension (HTN), osteoarthritis, migraine (since menopause migraines were infrequent), knee replacement, arthritis and menopause. The patient had codeine allergy and seasonal allergy. The concomitant medications were taken by the patients (unspecified) within two weeks prior to COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On an unknown date in Mar2021 after first vaccination, the patient experienced moderate migraine headache and achy joints, which lasted for 2 days. On an unknown date in Apr2021 after second vaccination, the patient had recurrence of migraine headache for 3 days and achy joints for 2 days.  As the symptoms recurred the patient believed it was caused by the vaccine. The patient had a history of migraine and arthritis but these episodes did not follow normal triggers. No other effects were noted but the patient wanted to report the events for record purpose. Additional medical attention was not requested as the patient had called on day 4. The adverse events did not result in a visit to the doctors or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient received treatment with unspecified medications for the reported events. It was also reported that the episodes of migraine headache and achy joints did not respond to treatment medications as quickly as usual. The clinical outcome of the event moderate migraine headache and achy joints were resolved on an unknown date. No follow-up attempts are needed. No further information is expected.
Severe body pain and joint, severe acne, spot of skin, rash, migraine, changes of behavior, severe back pain, etc.  7/31/07 Received medical records from VAMC for 9/04-7/07 which reveal patient experienced chronic neck & LBP s/p fall in 2004, hallux valgus deformity & severe pes planus deformity & arthritis of bilat feet, acne, hypertriglyceridemia, headaches w/photophobia, myositis, left knee pain   Tx w/PT for neck & back pain.  8/3/07 Received vax record from patient.  Does not include lot #s. VAERS database updated w/same.
c/o dizziness approx 15 min after injection.  Sat for few min, felt better.  5:30pm c/o headache & nausea x1 hour, while at home.  Started taking 2 ibuprofen, advised to drink hot tea et broth.  Will recheck next day.
Pt to ED 11/8 for AMS, lethargy. Pt COVID+ 11/8. 11/9 pt in resp distress, transfer to ICU. 11/12 pt coughing up a moderate amount of brown/tan  Phlegm, thick. Also emesis noted small amount times one dark green in color. 11/15 Pt a/o x4, room air, complaints of chronic pain in left hip,  vital signs stable, afebrile. Pt discharged 11/21.
Woke up during then night crying with stomach pain, nausea, couldn't touch area where she had vaccine.  Felt ill for 3-4 days.
Patient sent an email  on 11/29/2021 to report that he has been diagnosed with a superficial thrombophlebitis, after several days of painful swelling on the lower leg.
Headache, Myalgia, left arm soreness, fatigue, sore throat Narrative:  N/A
right side face became swollen; teeth on her right side were aching; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (teeth on her right side were aching) and SWELLING FACE (right side face became swollen) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced TOOTHACHE (teeth on her right side were aching). On 21-Jan-2021, the patient experienced SWELLING FACE (right side face became swollen). On 20-Jan-2021, TOOTHACHE (teeth on her right side were aching) had resolved. At the time of the report, SWELLING FACE (right side face became swollen) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs and no treatment. It was reported that the patient had undergone RCT in January.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow up received on 08-Jun-2021, contains information about causality updation and the procedure undergone by the patient.
Fever of 100.3 x 3 days, systemic hives daily and continues as of today 1/21/21. Used an Epipen over the weekend due to face and mouth swelling. Been to Dr several times since 12/24/20. Prednisone and antihistamines given with minimal relief. Patient has missed several days of work due to  systemic swelling and hives covering her entire body.
Caller states that she got her 2nd dose of the COVID vaccine, and is wanting to know if it causes a UTI; This is a spontaneous report received from a non-contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (batch/lot number unknown) via an unspecified route of administration on an unknown date at 2nd dose, single for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient stated that she got her 2nd dose of the COVID vaccine, and was wanting to know if it caused a UTI. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Frequent muscle twitching at the location of the vaccine in the left arm.; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 11:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes type 2. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), metformin hydrochloride; sitagliptin phosphate monohydrate (JANUMET), metformin (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN and vitamin d nos (VITAMIN D); all for unknown indications from unknown dates. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 10Apr2021 at 07:00, the patient experienced frequent muscle twitching at the location of the vaccine in the left arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event frequent muscle twitching at the location of the vaccine in the left arm was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Mar2021 as dose 1, single (Lot number: EN6206), in left arm, on 29Mar2021 as dose 2, single (Lot number: ER8732), in left arm and on 01Sep2021 as dose 3 (booster), single (Lot number: FC3182) at the age of 48 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Ulcerative colitis" (unspecified if ongoing). Concomitant medication(s) included: CALCIUM; CENTRUM JR [MINERALS NOS;VITAMINS NOS]; GLUCOSAMINE; EMERGEN-C VITAMIN D & CALCIUM; FISH OIL; MUCINEX D, start date: 03Dec2022, stop date: 07Dec2022; NORGESTIMATE & ETHINYL ESTRADIOL; TYLENOL, start date: 01Dec2022, stop date: 05Dec2022; VITAMIN C [ASCORBIC ACID]. Past drug history included: Remicade for immunosuppressant, notes: taking immunosuppressant, Remicade. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Dec2022) Negative, notes: Tested negative on day 6 and felt better; (12Dec2022) Positive, notes: Rebound covid positive test on day 11. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient was in other medication in 2weeks, took full course of Paxlovid Day1-5. Tested negative on day 6 and felt better. On day 9 feeling unwell. Rebound covid positive test on day 11 and COVID 19 treatment received with Paxlovid from 02Dec2022 to 06Dec2022.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201369695 same patient/drug, different dose/AE;
Headache, Myalgia, Arthralgia, Fatigue/ Chills Narrative:  Other Relevant History:
I lost hearing all hearing and developed tinnitus (loud ringing) in my right ear on the morning of Feb 15 (three days after receiving my first dose of the Moderna covid vaccine).
fatigue, low grade fever, chills, aches, covid arm rash, nausea, headache, stomachache. treated with otc nasal spray and tylenol.
Information has been received from a physician concerning a 46 year old Caucasian female with concurrent conditions of HIV, bipolar disorder, herpes zoster, chronic obstructive pulmonary disease, and allergies to cephalosporin, influenza vaccine, Thioridazine hydrochloride, metals, and seafood who on 3/29/04 at 12:15 was vaccinated IM in the right deltoid with a first dose of hepatitis B virus vaccine (lot # 646147/0626N). Adverse events following prior vaccinations at age 35 included hives/edema with influenza vaccine. Concomitant therapy included fluconazole, lorazepam, topiramate, aripiprazole, zolpidem tartrate, vitamins, oxycodone, albuterol sulfate (+) ipratropium bromide, pantoprazole sodium, lamivudine, zidovudine, lopinavir (+) ritonavir, and ferrous gluconate. On 3/29/04, at 12:25 PM (previously reported as 15:00), the patient immediately developed a watery eye and later, left eye droop (also reported as 10 minutes after the vaccine, eye watered, twitched, and droopy, facial numbness on left side and lip drooped). On 3/30/04, the patient was seen in the office with left sided facial droop and slurred speech (also reported as by next day full left sided facial droop and slurred speech). The diagnosis was Bell's Palsy. No treatment was required, however, it was noted that the patient was going to the emergency room. The patient was seen in the ER and was given steroids and acyclovir for Bell's Palsy. Unspecified medical attention was sought. There was no product quality complaint involved. The patient recovered on 5/20/04. The physician considered Bell's Palsy to be significantly disabling. Additional information has been requested.
2nd vaccine on 9/12/2021. Started with painful red rash on chest 9/22/2021 at 3:30pm which spread to face. Symptoms temporarily relieved with Zyrtec for 4 hours. Rash continued to worsen to spread to under arm area. 9/23/2021 rash had spread to stomach, shoulders, and back. Presented to the ER with the symptoms. Was given steroids, and Benadryl via IV. 9/24/2021 woke up with swollen eyes, face, neck. Rash worsened on chest, shoulders, back, stomach, and legs. Total body swelling, shortness of breath, and muscle pains. Presented to the ER and received no care. Struggled to breath as I drove home to get a dose of Benadryl. Provided temporary relief. Symptoms still a problem as of 9/27/2021.
terrible car accident just after having the shots; This spontaneous case was reported by a consumer and describes the occurrence of ROAD TRAFFIC ACCIDENT (terrible car accident just after having the shots) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Cardiovascular disease, unspecified (Cardiovascular disease), Small intestine carcinoma (cancer in the small intestines), Diabetes and Cancer (unspecified).   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ROAD TRAFFIC ACCIDENT (terrible car accident just after having the shots). At the time of the report, ROAD TRAFFIC ACCIDENT (terrible car accident just after having the shots) outcome was unknown.            The patient had been taking a lot unspecified medicines for her maintenance medication.   The Moderna Booster shot was scheduled for the patient on 03-Jan-2022.  No treatment information was provided by the reporter.
information has been received from a consumer concerning her 19 year old female daughter who was vaccinated with a first and second dose of Gardasil. It was reported that prior to getting the scheduled third dose of the vaccine, her daughter was diagnosed with mononucleosis. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
3/27/21 @ 01:00 AM, severe vomiting, the same effects as very severe flu. Vomiting continued around 12:10 PM
This spontaneous report as received from a physician via a field representative refers to a female patient of unknown age. On 14-FEB-2014 the patient was vaccinated with a dose of M-M-R II (lot # J007156) (1 viral, injection). On 24-FEB-2014, the patient developed measles like rash after receiving M-M-R II. The patient sought medical attention by seeing physician. There was no treatment given. The outcome of the event was unknown. Additional information has been requested.
Mild/moderate fatigue, muscle aches, brain fog  developed 12 hours post-injection, sustained for 4 days post-vaccination and persisting/increasing. Moderate headache for 24-36 hours post-vaccination. All treated with OTC dosages of ibuprofen. Injection site soreness to touch developed 36-48 hours post-injection and sustained at 4 days.
This spontaneous report as received from a physician refers to a 15 year old male patient. On an unspecified date, the patient began the GARDASIL series. The physician reported that the patient received the second dose of GARDASIL (lot #, route and dose not reported) on 04-OCT-2012 and on 14-FEB-2013 developed psoriasis. The patient received the third dose of GARDASIL (lot #, route and dose not reported) on 26-APR-2013, and the patient still presented with psoriasis. The patient sought medical attention by office visit. The patient was treated with ELIDEL cream, coal tar 20% solution and calcipotriene cream. At the time of reporting, the patient was not recovered. Additional information has been requested.
Patient C/O burning in the ear. systolic BP ranging between 176 and 200; Diastolic BP ranging between 100 and  118. Paulse ranging between 79 and 81.
Patient started having itching starting at the ankles, circumfrentially, symmetrical on both legs. This continued upward the legs to the body. Back and back of arms. Rash. Treatment with anti-histamine (anti-H1) drug and acid reducer anti-H2 famotidine. Patient presented a rash after receiving the vaccine. The notes informed us that it started next day after receiving the vaccine.
5 cm diameter indurated area left deltoid, emanating from the deep tissue. It is slightly tender. No erythema and full range of motion of shoulder, no lymphadenopathy.
MMR, Comvax (ABV/HIB), Varicella, Flu shots given on 12/17/04. Had Febrile Sz on 12/19/2004 associated with fever.
swelling of the feet and hands; This case was reported by a consumer via interactive digital media and described the occurrence of peripheral swelling in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced peripheral swelling. On an unknown date, the outcome of the peripheral swelling was unknown.   It was unknown if the reporter considered the peripheral swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had swelling of the feet and hands and wanted to know does it cause the symptoms.
PT STATES THAT SHE HAD "ONE SPOT" OF SHINGLES IN MARCH/APRIL, THEN A MILD CASE OF SHINGLES IN NOVEMBER THAT SURFACED ON HER LEFT SIDE (THE OPPOSITE SIDE OF HER SHINGLE CASES PRE-ZOSTAVAX.
First dose - at 20 min - swelling of the hand same side as the vaccine - right hand.   Ear pain and hearing loss.  Worsening memory loss afterwards.  Problems with pulse - very low / bradyarrhymias noted. Second Vaccine for Covid- at pharmacy began tremor soon after injection. both hands, fever. self limited.  tiredness.
Per mom, quarter sized area of redness around the site of injection.  Looks blotchy, feels soft.  Area of redness is slightly tender.